AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,376,000 | +105.9% | 355,296 | +2.1% | 0.00% | +100.0% |
| Q2 2022 | $2,611,000 | -15.8% | 348,021 | +2.1% | 0.00% | 0.0% |
| Q1 2022 | $3,101,000 | +35.9% | 340,719 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $2,282,000 | -32.7% | 324,982 | +9.3% | 0.00% | 0.0% |
| Q3 2021 | $3,391,000 | -32.9% | 297,385 | -5.8% | 0.00% | -50.0% |
| Q2 2021 | $5,054,000 | -5.4% | 315,652 | +5.6% | 0.00% | 0.0% |
| Q1 2021 | $5,340,000 | +38.7% | 298,801 | +4.9% | 0.00% | 0.0% |
| Q4 2020 | $3,849,000 | +15.9% | 284,856 | +1.0% | 0.00% | 0.0% |
| Q3 2020 | $3,321,000 | -15.5% | 282,089 | +5.9% | 0.00% | 0.0% |
| Q2 2020 | $3,932,000 | +10.4% | 266,383 | +1.0% | 0.00% | 0.0% |
| Q1 2020 | $3,560,000 | -43.0% | 263,685 | +2.0% | 0.00% | -33.3% |
| Q4 2019 | $6,246,000 | +29.6% | 258,394 | +3.1% | 0.00% | 0.0% |
| Q3 2019 | $4,818,000 | -30.6% | 250,643 | +6.7% | 0.00% | -25.0% |
| Q2 2019 | $6,942,000 | -33.0% | 234,913 | +7.6% | 0.00% | -42.9% |
| Q1 2019 | $10,367,000 | +39.5% | 218,245 | +6.0% | 0.01% | +16.7% |
| Q4 2018 | $7,433,000 | -41.7% | 205,886 | -0.6% | 0.01% | -25.0% |
| Q3 2018 | $12,754,000 | -5.4% | 207,213 | +3.8% | 0.01% | -20.0% |
| Q2 2018 | $13,487,000 | +36.3% | 199,659 | +9.5% | 0.01% | +25.0% |
| Q1 2018 | $9,893,000 | +0.6% | 182,345 | +10.8% | 0.01% | 0.0% |
| Q4 2017 | $9,836,000 | +32.6% | 164,605 | +7.8% | 0.01% | +33.3% |
| Q3 2017 | $7,420,000 | +2.1% | 152,668 | +10.4% | 0.01% | -14.3% |
| Q2 2017 | $7,268,000 | +17.7% | 138,289 | +1.6% | 0.01% | +16.7% |
| Q1 2017 | $6,173,000 | +21.0% | 136,106 | +1.0% | 0.01% | 0.0% |
| Q4 2016 | $5,100,000 | +27.9% | 134,718 | +27.5% | 0.01% | +20.0% |
| Q3 2016 | $3,988,000 | +503.3% | 105,668 | +181.5% | 0.01% | +400.0% |
| Q2 2016 | $661,000 | +82.1% | 37,544 | +25.8% | 0.00% | – |
| Q1 2016 | $363,000 | -50.1% | 29,844 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $727,000 | +37.2% | 29,844 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $530,000 | +1.1% | 29,844 | +0.7% | 0.00% | 0.0% |
| Q2 2015 | $524,000 | +4.4% | 29,644 | +85.3% | 0.00% | 0.0% |
| Q1 2015 | $502,000 | +7.3% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $468,000 | +41.0% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $332,000 | -16.4% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $397,000 | +66.8% | 16,000 | +42.9% | 0.00% | – |
| Q1 2014 | $238,000 | +17.8% | 11,200 | 0.0% | 0.00% | – |
| Q4 2013 | $202,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|